These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28330653)

  • 1. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.
    Kouranos V; Tzelepis GE; Rapti A; Mavrogeni S; Aggeli K; Douskou M; Prasad S; Koulouris N; Sfikakis P; Wells A; Gialafos E
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1437-1447. PubMed ID: 28330653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia.
    Hennig A; Salel M; Sacher F; Camaioni C; Sridi S; Denis A; Montaudon M; Laurent F; Jais P; Cochet H
    Europace; 2018 Sep; 20(FI2):f179-f191. PubMed ID: 29069369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis.
    Athwal PSS; Chhikara S; Ismail MF; Ismail K; Ogugua FM; Kazmirczak F; Bawaskar PH; Elton AC; Markowitz J; von Wald L; Roukoz H; Bhargava M; Perlman D; Shenoy C
    JAMA Cardiol; 2022 Oct; 7(10):1057-1066. PubMed ID: 36103165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of speckle tracking echocardiography for the prediction of cardiac involvement in patients with biopsy-proven sarcoidosis.
    Jankowska H; Dorniak K; Dudziak M; Glińska A; Sienkiewicz K; Kulawiak-Gałąska D; Fijałkowska J; Dubaniewicz A; Hellmann M
    Echocardiography; 2024 Mar; 41(3):e15777. PubMed ID: 38526991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
    Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
    J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of RV Abnormalities on CMR in Patients With Known or Suspected Cardiac Sarcoidosis.
    Wang J; Zhang J; Hosadurg N; Iwanaga Y; Chen Y; Liu W; Wan K; Patel AR; Wicks EC; Gkoutos GV; Han Y; Chen Y
    JACC Cardiovasc Imaging; 2023 Mar; 16(3):361-372. PubMed ID: 36752447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of late gadolinium enhancement to improve outcomes prediction in patients referred for cardiovascular magnetic resonance after echocardiography.
    Wong TC; Piehler K; Puntil KS; Moguillansky D; Meier CG; Lacomis JM; Kellman P; Cook SC; Schwartzman DS; Simon MA; Mulukutla SR; Schelbert EB
    J Cardiovasc Magn Reson; 2013 Jan; 15(1):6. PubMed ID: 23324403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.
    Maceira AM; Prasad SK; Hawkins PN; Roughton M; Pennell DJ
    J Cardiovasc Magn Reson; 2008 Nov; 10(1):54. PubMed ID: 19032744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
    Trivieri MG; Robson PM; Vergani V; LaRocca G; Romero-Daza AM; Abgral R; Devesa A; Azoulay LD; Karakatsanis NA; Parikh A; Panagiota C; Palmisano A; DePalo L; Chang HL; Rothstein JH; Fayad RA; Miller MA; Fuster V; Narula J; Dweck MR; Morgenthau A; Jacobi A; Padilla M; Kovacic JC; Fayad ZA
    JACC Cardiovasc Imaging; 2024 Apr; 17(4):411-424. PubMed ID: 38300202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening tools for the detection of clinically silent cardiac sarcoidosis.
    De Bortoli A; Dawson KA; Hashem D; Spence SD; Pena E; Inacio JR; Nery P; Juneau D; Dwivedi G; Beanlands R; Paterson I; Birnie DH
    Respir Med; 2024 Apr; 224():107538. PubMed ID: 38340906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases.
    Okasha O; Kazmirczak F; Chen KA; Farzaneh-Far A; Shenoy C
    J Am Heart Assoc; 2019 May; 8(10):e011253. PubMed ID: 31070111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Impact and Prognostic Value of Cardiac Magnetic Resonance in Patients With Ventricular Arrhythmias.
    Ge Y; Antiochos P; Seno A; Qamar I; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Tedrow UB; Stevenson WG; Kwong RY
    JACC Cardiovasc Imaging; 2023 Dec; 16(12):1536-1549. PubMed ID: 37318392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis.
    Ochs MM; Fritz T; Arenja N; Riffel J; Andre F; Mereles D; Siepen FAD; Hegenbart U; Schönland S; Katus HA; Friedrich MGW; Buss SJ
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):87. PubMed ID: 29121956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcome in a contemporary cardiac sarcoidosis population: Role of brain natriuretic peptide, left ventricular function and myocardial inflammation.
    Kouranos V; Khattar RS; Okafor J; Ahmed R; Azzu A; Baksi JA; Wechalekar K; Cowie MR; Wells AU; Lüscher TF; Sharma R
    Eur J Heart Fail; 2023 Dec; 25(12):2287-2298. PubMed ID: 37877328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
    Petri H; Ahtarovski KA; Vejlstrup N; Vissing J; Witting N; Køber L; Bundgaard H
    J Cardiovasc Magn Reson; 2014 Aug; 16(1):59. PubMed ID: 25086734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic approach for cardiac involvement in sarcoidosis.
    Darlington P; Gabrielsen A; Cederlund K; Kullberg S; Grunewald J; Eklund A; Sörensson P
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):11-17. PubMed ID: 32476931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging as a Predictor of Survival Free of Life-Threatening Arrhythmias and Transplantation in Cardiac Sarcoidosis.
    Ekström K; Lehtonen J; Hänninen H; Kandolin R; Kivistö S; Kupari M
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27139734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure.
    Morrissey RP; Philip KJ; Schwarz ER
    Cardiovasc J Afr; 2010; 21(3):158-63. PubMed ID: 20532456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of
    Kaushik P; Patel C; Gulati GS; Seth S; Parakh N; Randeep Guleria ; Kumar R; Gupta P; Bal C
    Ann Nucl Med; 2021 Sep; 35(9):1058-1065. PubMed ID: 34125376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.